Earnings NewsCrinetics Pharmaceuticals GAAP EPS of -$0.85 misses by $0.01, revenue of $2.67M beats by $2.43MMay 04, 2023 5:31 PM ETCrinetics Pharmaceuticals, Inc. (CRNX)By: Gaurav Batavia, SA News Editor Crinetics Pharmaceuticals press release (NASDAQ:CRNX): Q1 GAAP EPS of -$0.85 misses by $0.01. Revenue of $2.67M (-14.7% Y/Y) beats by $2.43M. Recommended For YouCommentsNewestPublishHave a tip? Submit confidentially to our News team. Found a factual error? Report here.More Trending NewsCharlie Munger, Warren Buffett's associate, dies at 99: Berkshire HathawayUS Steel gains on report five parties are expected to make bidsApple ending credit card partnership with Goldman Sachs - WSJCrowdStrike beats in Q3, but forecast disappointsRocket Software to acquire OpenText’s AMC business for over $2 billionSee More »About CRNXSymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield (TTM)Rev Growth (YoY)Short InterestPrev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgCRNX--Crinetics Pharmaceuticals, Inc.RCKT--Rocket Pharmaceuticals, Inc.IDYA--IDEAYA Biosciences, Inc.XENE--Xenon Pharmaceuticals Inc.RYTM--Rhythm Pharmaceuticals, Inc.CompareTrending AnalysisTrending News